BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36070933)

  • 1. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10.
    Qi J; Li J; Bie B; Shi M; Zhu M; Tian J; Zhu K; Sun J; Mu Y; Li Z; Guo Y
    Phytother Res; 2023 Jan; 37(1):295-309. PubMed ID: 36070933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.
    Bie B; Sun J; Li J; Guo Y; Jiang W; Huang C; Yang J; Li Z
    Cell Physiol Biochem; 2017; 41(4):1519-1531. PubMed ID: 28351032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression.
    Niu C; Wang L; Ye W; Guo S; Bao X; Wang Y; Xia Z; Chen R; Liu C; Lin X; Huang X
    J Cell Physiol; 2020 Sep; 235(9):6307-6320. PubMed ID: 32037568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
    Bi HQ; Li ZH; Zhang H
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
    Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
    Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.